Live
- Congress Challenges PM Modi's Allegations: Calls Out "Falsehoods" Amidst Electoral Rhetoric
- CPI(M) leader seeks Calcutta HC’s attention over Bengal CM's anti-judiciary comments
- Aparna Yadav Challenges Akhilesh Yadav's Candidacy In Kannauj: No Longer A Smooth Ride For Samajwadi Party
- A constable who helped an old woman in a very dangerous place
- WBSSC Claims Eligibility For 19,000 Dismissed Staff Amidst Teacher Recruitment Scandal
- Tollywood’s shifting landscape: The growing influence of OTT platforms
- YSR Congress Party MLA candidate KK Raju campaigns in 23rd Ward Priyadarshini Colony
- Leaders and Residents Welcome TDP Candidates Pulivarthi Nani and Daggumalla Prasada Rao in Tirupati
- 30 Families Switch Allegiance from YSR Congress to Telugu Desam Party in Batladinne Village
- Mannara Chopra’s refreshing photoshoot brings summer vibes
Granules India arm gets USFDA nod for an antiviral
Highlights
Drug firm Granules India Ltd on Wednesday said its foreign arm has received approval from the US health regulator for Valganciclovir hydrochloride oral solution, an antiviral medication.
Hyderabad: Drug firm Granules India Ltd on Wednesday said its foreign arm has received approval from the US health regulator for Valganciclovir hydrochloride oral solution, an antiviral medication.
"The US Food & Drug Administration (USFDA) has approved the Abbreviated New Drug Application (ANDA) filed by Granules Pharmaceuticals, Inc, a-wholly owned foreign subsidiary of Granules India Ltd for Valganciclovir hydrochloride for oral solution, 50 mg/ml," the company said in a regulatory filing.
Next Story
ADVERTISEMENT
